These results indicated the decreased cell proliferation rates led by knocking down RIOK1 could only be rescued by the wildtype NPM1 overexpression, which further emphasized the role of NPM1 Ser125 phosphorylation in medicating RIOK-dependent regulation of the tumor cell proliferation. The gene discussed is NPM1; the disease is neoplasm.